Upload Button Icon Add office photos
filter salariesFilter salaries by

Ferring Therapeutics Manager Supply Chain Management salaries in Navi Mumbai

Annual salary range
Select experience
₹15.9 Lakhs - ₹20.3 Lakhs
Low Confidence
info icon
Low confidence means that this average salary is based on data that was reported by very few people.
Salary of majority employees
unlock blur
unlock blur

Interested in this particular role?

Last Updated: 9 Mar 2023

Companies similar to Ferring Therapeutics for Manager Supply Chain Management in Navi Mumbai

Logo
Ferring Therapeutics Manager Supply Chain Management Salary

22 years exp. (AmbitionBox Estimate)

unlock blur

₹15.9 L/yr - ₹20.3 L/yr

vs
Company name Avg Annual Salary Open Jobs
unlock blur

₹13.5 L/yr - ₹19 L/yr

arrow icon 8% less
Logo
Jio Manager Supply Chain Management Salary

13 - 20 years exp. (3 salaries)

unlock blur

₹12.3 L/yr - ₹15 L/yr

arrow icon 30% less
Logo
VVF Manager Supply Chain Management Salary

10 - 12 years exp. (3 salaries)

unlock blur

₹10.8 L/yr - ₹13.8 L/yr

arrow icon 32% less
Manager Supply Chain Management salary at Ferring Therapeutics ranges between ₹15.9 Lakhs to ₹20.3 Lakhs per year for employees with 22 years of experience. Salary estimates are based on 1 latest salaries received from various employees of Ferring Therapeutics.

Salary related reviews for Ferring Therapeutics

Full Time

 · 

Procurement & Supply Chain Department

5.0
  •  posted on 16 Mar 2023

5.0
 for  Salary and Benefits

Likes

Process in place which aid in better working. Work Life balance can be maintained. The culture is good. Role gives ample exposure and allows you to connect with various functions.

read more
  • Salary - Excellent
    +6 more

Dislikes

None ....Good company to work with ....

see more salary related reviews

Tell us how to improve this page.

Ferring Therapeutics Manager Supply Chain Management salary in Navi Mumbai ranges between ₹15.9 Lakhs to ₹20.3 Lakhs. This is an estimate based on latest salaries received from employees of Ferring Therapeutics.